Plain-English translation of NCT06756334 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing whether a newer imaging scan called can detect prostate cancer as well as or better than an existing scan called . Both scans use a special radioactive dye injected into your bloodstream to light up cancer cells so doctors can see them more clearly. The study will compare how well each scan finds cancer, spots where cancer has returned, and whether it has spread to other parts of your body.
Doctors need reliable ways to find prostate cancer early and detect if it comes back after treatment. This study will help determine if the newer imaging method is more accurate or easier to use than the current standard, which could improve how doctors diagnose and monitor prostate cancer.
You likely qualify if…
You likely don't qualify if…
You will visit the hospital twice over two consecutive weeks. During each visit, you'll receive an injection of a radioactive dye into your vein, and then you'll have a PET/CT scan—a special imaging procedure that takes pictures of your body to find cancer cells. Each scan takes about an hour. After both scans are complete, you may be asked to have a biopsy or surgery so doctors can confirm the results, or your existing test results will be used to compare how accurate the two imaging methods are.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
China